Literature DB >> 2878060

Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma.

H Sugiyama, H Doi, K Yamaguchi, Y Tsuji, T Miyamoto, S Hino.   

Abstract

In order to shed light on the mode of HTLV-I infection by mother-to-child transmission, we examined sera of school children in a highly endemic town on two separate occasions at a 6-year interval. The carrier rates in ages 15-17, 8.7 and 2.1%, were significantly higher than that in ages 6-8, 1.7 and 0.4%, in studies. The latter survey showed a significantly lower carrier rate in each age group. Moreover, the carrier rates of those students born in 1965-1967 and 1968-1970 were stable in the interval. The data suggested that carrier rates of children at certain ages are reflected by the date of birth rather than by age. A prospective survey of children born of carrier mothers found the overall carrier rate to be approximately 25%, which did not increase with their age. There was no sexual difference in the carrier rate of children: 5/25 in male and 9/34 in females (X2 = 0.3). Carrier mothers could be separated into two groups: HTLV-I antigen-positive mothers and negative mothers. Nine out of 19 antigen-positive mothers (47%) and 2 of 19 antigen-negative mothers (11%) had carrier children (X2 = 6.3). Twelve of 30 children born of antigen-positive carrier mothers (40%) were carriers, in contrast to 2 of 24 children (8%) of antigen-negative mothers (X2 = 7.8). Furthermore, 12 of 14 carrier children (86%) were of antigen-positive mothers. This suggests that postnatal but early transmission of HTLV-I plays a significant role in the maintenance of HTLV-I endemy and the development of adult T-cell leukemia/lymphoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878060     DOI: 10.1002/jmv.1890200307

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.

Authors:  Paola Miyazato; Jun-ichirou Yasunaga; Yuko Taniguchi; Yoshio Koyanagi; Hiroaki Mitsuya; Masao Matsuoka
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 2.  Cancer burden and trends in the Asian Pacific Rim region.

Authors:  Binh H Yang; D Maxwell Parkin; Lin Cai; Zuo Feng Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2004 Apr-Jun

3.  Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Authors:  Daniela Romer; David W Brighty; Cynthia L Robson; Quentin J Sattentau
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

4.  Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.

Authors:  S Hino; S Katamine; T Miyamoto; H Doi; Y Tsuji; T Yamabe; J E Kaplan; D L Rudolph; R B Lal
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto.

Authors:  J Chiavetta; J Nusbacher; F Tam; A Wall; J Steaffens; H Lee
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

6.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

7.  Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki.

Authors:  Shigeo Hino
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

8.  Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia.

Authors:  S Momita; S Ikeda; T Amagasaki; H Soda; Y Yamada; S Kamihira; M Tomonaga; K Kinoshita; M Ichimaru
Journal:  Jpn J Cancer Res       Date:  1990-09

9.  Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis.

Authors:  K Nomata; T Nakamura; H Suzu; Y Yushita; H Kanetake; T Sawada; S Ikeda; S Hino; S Nagataki; Y Saito
Journal:  Jpn J Cancer Res       Date:  1992-06

10.  A maternal risk factor for mother-to-child HTLV-I transmission: viral antigen-producing capacities in culture of peripheral blood and breast milk cells.

Authors:  M Yoshinaga; S Yashiki; T Oki; T Fujiyoshi; Y Nagata; S Sonoda
Journal:  Jpn J Cancer Res       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.